Literature DB >> 3895053

Genetic galactosylceramidase deficiency (globoid cell leukodystrophy, Krabbe disease) in different mammalian species.

K Suzuki, K Suzuki.   

Abstract

Globoid cell leukodystrophy (Krabbe disease) in man is a rare genetic disorder caused by deficiency of galactosylceramidase activity. Clinical and pathological manifestations are almost exclusively confined to the nervous system, particularly to the white matter and the peripheral nerve. The disease also occurs in four other mammalian species: dog, cat, sheep and mouse. Except for the feline disease, for which enzymatic information is lacking, these animal models are genetically equivalent to the human disease. The clinical and pathological features are fundamentally similar in all species, as might be expected from the same underlying genetic defect. Nevertheless, significant species differences are observed in the clinical course, severity of pathological alterations, and analytical biochemistry. These genetically "authentic" animal models provide an invaluable tool for studies of the rare human genetic disorder. Results of studies already done and the future potentials are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895053     DOI: 10.1007/bf02834075

Source DB:  PubMed          Journal:  Neurochem Pathol        ISSN: 0734-600X


  11 in total

Review 1.  Leukodystrophy and bone marrow transplantation: role of mixed hematopoietic chimerism.

Authors:  C L Kaufman; S T Ildstad
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

Review 3.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

4.  An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.

Authors:  Xiufang Pan; Scott A Sands; Yongping Yue; Keqing Zhang; Steven M LeVine; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2019-07-18       Impact factor: 5.695

5.  Characteristic inclusions in the kidney of canine globoid cell leukodystrophy.

Authors:  K Suzuki
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  High resolution MRI anatomy of the cat brain at 3 Tesla.

Authors:  Heather L Gray-Edwards; Nouha Salibi; Eleanor M Josephson; Judith A Hudson; Nancy R Cox; Ashley N Randle; Victoria J McCurdy; Allison M Bradbury; Diane U Wilson; Ronald J Beyers; Thomas S Denney; Douglas R Martin
Journal:  J Neurosci Methods       Date:  2014-02-10       Impact factor: 2.390

7.  Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy.

Authors:  Juan T Borda; Xavier Alvarez; Mahesh Mohan; Marion S Ratterree; Kathrine Phillippi-Falkenstein; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

8.  MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology.

Authors:  Kumiko Ijichi; Graham D Brown; Craig S Moore; Jean-Pyo Lee; Paige N Winokur; Roberto Pagarigan; Evan Y Snyder; Ernesto R Bongarzone; Stephen J Crocker
Journal:  Glia       Date:  2013-02-13       Impact factor: 7.452

Review 9.  Ceramide function in the brain: when a slight tilt is enough.

Authors:  Chiara Mencarelli; Pilar Martinez-Martinez
Journal:  Cell Mol Life Sci       Date:  2012-06-24       Impact factor: 9.261

10.  Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.

Authors:  E Costantino-Ceccarini; A Luddi; M Volterrani; M Strazza; M A Rafi; D A Wenger
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.